Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome

Bayram, Neriman; Wely, Madelon van; Vandekerckhove, Patrick; Lilford, R J; Veen, Fulco van der

doi:10.1002/14651858.cd000412

Search citation statements

Order By: Relevance

Paper Sections

Select...

Pulsatile Gonadotrophin-releasing Hormone1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2003

2021

Publication Types

Select...

Article4

Book2

Relationship

Self Cite0

Independent6

Authors

Journals

Cited by 7 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A systematic review of three RCTs, one non-RCT and 18 uncontrolled case series studies found insufficient evidence for or against a beneficial effect of pulsatile GnRH in women with clomifene citrate-resistant PCOS when compared with other ovulatory agents (hMG, FSH, with and without pretreatment with GnRHa). 574…”

Section: Pulsatile Gonadotrophin-releasing Hormonementioning

confidence: 99%

Pharmacokinetics, safety, and tolerability of Pentoxifylline intravaginal gel for subfertile/ infertile couples with low sperm quality: phase I randomized controlled clinical trial in healthy women

Ballester¹,

Puntes²,

Coimbra³

et al. 2021

Trends Med

View full text Add to dashboard Cite

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.The publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check its accuracy by consulting other pharmaceutical literature.

show abstract

Section: Pulsatile Gonadotrophin-releasing Hormonementioning

confidence: 99%

Pharmacokinetics, safety, and tolerability of Pentoxifylline intravaginal gel for subfertile/ infertile couples with low sperm quality: phase I randomized controlled clinical trial in healthy women

Ballester¹,

Puntes²,

Coimbra³

et al. 2021

Trends Med

View full text Add to dashboard Cite

show abstract

Polycystic Ovary Syndrome

Dmitrović¹,

Legro²

Contemporary Endocrinology

View full text Add to dashboard Cite

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

Palomba

Orio

Russo

et al. 2004

J Endocrinol Invest

View full text Add to dashboard Cite

Polycystic ovary syndrome (PCOS) is one of the most common endocrine diseases affecting women of fertile age, and is characterized by hyperandrogenism, chronic anovulatory cycles and oligomenorrhea or amenorrhea. Given the repercussions of chronic anovulation on sterility, PCOS is a heavy social burden. Here we describe the procedures used to induce ovulation in PCOS patients, the surgical approach and medical treatments that are still being experimented.

show abstract

Pulsatile luteinising hormone releasing hormone for ovulation induction in subfertility associated with polycystic ovary syndrome

Cited by 7 publications

References 35 publications

Pharmacokinetics, safety, and tolerability of Pentoxifylline intravaginal gel for subfertile/ infertile couples with low sperm quality: phase I randomized controlled clinical trial in healthy women

Pharmacokinetics, safety, and tolerability of Pentoxifylline intravaginal gel for subfertile/ infertile couples with low sperm quality: phase I randomized controlled clinical trial in healthy women

Polycystic Ovary Syndrome

Is ovulation induction still a therapeutic problem in patients with polycystic ovary syndrome?

Contact Info

Product

Resources

About